Merrimack Pharmaceuticals, Inc. Share

Market capitalization is the share price multiplied by the number of shares issued.

Merrimack Pharmaceuticals, Inc.

Enterprise value (EV) is a measure of the value of a company regardless of its financing. It is calculated as follows:
EV = market capitalization - cash + debt.

Enterprise Value explained simply

Merrimack Pharmaceuticals, Inc.

The P/E ratio or price/earnings ratio TTM (Trailing Twelve Months) over the last 12 months describes the ratio of the share price to earnings per share.

Merrimack Pharmaceuticals, Inc.

If you divide the enterprise value by the free cash flow of the last 12 months, you obtain an important key figure for assessing the valuation of companies - even if they are not yet generating profits.

Merrimack Pharmaceuticals, Inc.

The P/B ratio TTM (Trailing Twelve Months) over the last 12 months describes the ratio of the share price to the book value per share.

Merrimack Pharmaceuticals, Inc.

Turnover TTM (Trailing Twelve Months) represents the sum of all revenues of a company for its products, services or other items within the last 12 months.

Merrimack Pharmaceuticals, Inc.

EBIT or the operating result represents the profit or loss after deducting direct costs (cost of sales), sales, marketing, administrative, research and development costs and depreciation and amortization.

Merrimack Pharmaceuticals, Inc.

The free cash flow TTM (Trailing Twelve Months) provides information on how much of the profit generated over the last 12 months remains in the company's coffers and is therefore available for profit distributions, share buybacks or debt repayment.

Merrimack Pharmaceuticals, Inc.

Cash is defined as cash and cash equivalents (i.e. cash items of very high value).

Merrimack Pharmaceuticals, Inc.

EPS TTM (Trailing Twelve Months) or earnings per share represents the profit per share over the last 12 months. The company's net profit is divided by the number of shares.

Merrimack Pharmaceuticals, Inc.